199
Views
6
CrossRef citations to date
0
Altmetric
Articles

Physiotherapy Management of Fibromyalgia: What do we know and how may this Affect Clinical Practice?

Pages 85-91 | Published online: 05 Sep 2013

REFERENCES

  • The International Association for the Study of Pain. The need of taxonomy. Pain 1979;6:247–52.
  • Johnson MI. The physiology of the sensory dimensions of clinical pain. Physiotherapy 1997; 83:526–36.
  • Yunus MB, Masi AT, Calabro JJ, et al. Primary fibromyalgia (fibrositis). Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981;11:151–71.
  • Bossevain MD, McCain GA. Toward an integrated understanding of fibromyalgia syndrome. II. Psychological and phenomenological aspects. Pain 1991;45:239–48.
  • Mengshoel AM, Vøllestad NK, Førre Ø. Pain and fatigue induced by exercise in fibromyalgia patients and sedentary healthy subjects. Clin Exp Rheumatol 1995; 13:477–82.
  • Henriksson C, Burchardt CS. Impact of fibromyalgia on everyday life: a study of women in the USA and Sweden. Disabil Rehabil 1996; 18:241–8.
  • Forseth KØ, Gran JT, Husby G. A population study of the incidence of fibromyalgia among women aged 26–55 yr. Br J Rheumatol 1997; 36:1318–23.
  • Wolfe F. The epidemiology of fibromyalgia. In: Jacobsen S, Danneskiold-Samsoe B, Lund B (eds) Musculoskeletal Pain, Myofascial Pain Syndrome, and the Fibromyalgia Syndrome. New York: Hayworth Medical Press, 1992:149–52.
  • Mengshoel AM. Fibromyalgia and responses to exercise. J Manual Manipulative Ther 1998; 6:144–50.
  • Consensus document on fibromyalgia: the Copenhagen declaration. J Musculoskeletal Pain 1993;1:295–312.
  • Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation (ed). J Rheumatol 1992; 19:846–50.
  • Russell IJ, Væroy H, Javors M, et al. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550–6.
  • Goldenberg DL, Mayskiy M, Mossey CJ, et al. A randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852–9.
  • Crofford LJ. Neuroendocrine abnormalities in fibromyalgia and related disorders. Am J Med Sci 1998; 315:359–66.
  • Neeck G, Riedel W. Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress? In: Masi A (ed.) Fibromyalgia and Myofascial Pain Syndrome. Edinburgh: Bailliére Tindall, 1994:763–76.
  • Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37:1583–92.
  • Griep EN, Boersma JW, deKloet ER. Altered reactivity of hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20:469–74.
  • van Denderen JC, Boersma JW, Zeinstra P, et al. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheumatol 1992; 21:35–7.
  • Mengshoel AM, Saugen E, Førre Ø, et al. Muscle fatigue in early fibromyalgia. J Rheumatol 1995; 22:143–50.
  • Værøy H, Quiao Z, Mørkrid L, et al. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989;16:1460–5.
  • Martininez-Lavin M, Hermosillo AG, Mendoza C, et al. Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 1997; 24:714–8.
  • Elam M, Johansson G, Wallin BG. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992;48:371–5.
  • Guccione AA. Physical therapy for musculoskeletal syndromes. Rheum Dis Clin North Am 1996; 22:551–62.
  • Hislop HJ. The not-so-impossible dream. Phys Ther 1975; 55:1069–80.
  • Sahrman SA. Diagnosis by the physical therapist — a prerequisite for treatment: a special communication. Phys Ther 1988;68:1703–6.
  • Verbrugge LM, Jette AM. The disablement process. Soc Sci Med 1994; 38:1–14.
  • Mengshoel AM. Physiotherapy and fibromyalgia: a literature review. Adv Physiother 1999; 1:73–82.
  • Mannerkorpi K, Ekdahl C. Assessment of functional limitation and disability in patients with fibromyalgia. A literature review. Scand J Rheumatol 1997;26:4–13.
  • Mannerkorpi K, Svantesson U, Carlsson J, et al. Tests of functional limitations in fibromyalgia syndrome: a reliability study. Arthritis Care Res 1999; 12:193–9.
  • Burchardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991;18:728–33.
  • Feine JS, Lund JP. An assessment of the efficacy of physical therapy and physical modalities for the control of chronic musculoskeletal pain. Pain 1997; 71:5–23.
  • McCain GA. Role of physical fitness training in the fibrositis/fibromyalgia syndrome. Am J Med 1986; 81:73–7.
  • McCain GA, Bell DA, Mai FM, et al. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988; 31:1135–41.
  • Wigers SH, Stiles TC, Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scand J Rheumatol 1996;25:77–86.
  • Martin L, Nutting A, Macintosh BR, et al. An exercise program in the treatment of fibromyalgia. J Rheumatol 1996; 23:1050–3.
  • Mengshoel AM, Komnæs HB, Førre Ø. The effects of twenty weeks of physical fitness training in female patients with fibromyalgia. Clin Exp Rheumatol 1992;10:345–9.
  • Burchardt CS, Mannerkorpi K, Hedenberg L, et al. A randomized controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994; 21:714–20.
  • Verstappen FTJ, van Santen-Hoeuftt HM, Bolwinjn P, et al. Effects of a group activity program for fibromyalgia patients on physical fitness and well being. J Muskuloskeletal Pain 1997; 5:17–28.
  • Gowans SE, deHueck A, Richardson M. A randomized, controlled trial of exercise and education for individuals with fibromyalgia. Arthritis Care Res 1999; 12:120–8.
  • Kogstad O, Hintringer F. Patients with fibromyalgia in pain school. J Musculoskeletal Pain 1993; 1:261–6.
  • Mason LW, Goolkasian P, McCain GA. Evaluation of multimodal treatment program for fibromyalgia. J Behav Med 1998;21:163–78.
  • Mengshoel AM, Forseth KØ, Haugen MA, et al. Multidisciplinary approach to fibromyalgia — a pilot study. Clin Rheumatol 1995; 14:165–70.
  • Vlaeyen JWS, Teeken-Gruben NJG, Goossens MEJB, et al. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol 1996;23:1237–45.
  • Turk DC, Okifuij A, Sinclair JD, et al. Interdisciplinary treatment for fibromyalgia syndrome: clinical and statistical significance. Arthritis Care Res 1998; 11:186–95.
  • Buckelew SP, Conway R, Parker J, et al. Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial. Arthritis Care Res 1998; 11:196–209.
  • Sunshine W, Field TM, Quintino O, et al. Fibromyalgia benefits from massage therapy and transcutaneous electrical stimulation. J Clin Rheumatol 1996; 2:18–22.
  • Kaada B. Behandling av fibromyalgi med lavfrekvent transkutan nervestimulering. (Norwegian) Tidsskr Nor Lœgeforen 1989;109:2992–5.
  • McBroom P, Walsh NE, Dumitru D. Electromyography in primary fibromyalgia syndrome. Clin J Pain 1988; 4:117–9.
  • Stokes MJ, Colter C, Klestov A, et al. Normal paraspinal muscle electromyographic fatigue characteristics in patients with primary fibromyalgia. Br J Rheumatol 1993; 32:711–6.
  • Svebak S, Anjia R, Kärstad SI. Task-induced electromyographic activation in fibromyalgia subjects and controls. Scand J Rheumatol 1993; 22:124–30.
  • Yestergaard-Poulsen P, Thomsen C, Norregaard J, et al. 3IP NMR spectroscopy and electromyography during exercise and recovery in patients with fibromyalgia. J Rheumatol 1995;22:1544–51.
  • Zidar J, Bäckman E, Bengtsson A, et al. Quantitative EMG and muscle tension in painful muscles in fibromyalgia. Pain 1990;40:249–54.
  • Ferraccioli G, Ghirelli L, Scita F, et al. EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 1987; 14:820–5.
  • Günther V, Mur E, Kinigadner U, et al. Fibromyalgia — the effect of relaxation and hydrogalvanic bath therapy on the subjective pain experience. Clin Rheumatol 1994; 13:573–8.
  • Kaplan KH, Goldenberg DL, Galvin-Nadeau M. The impact of a mediation-based stress reduction program in fibromyalgia. Gen Hosp Psych 1993; 15:284–9.
  • Ledingham J, Doherty S, Doherty M. Primary fibromyalgia syndrome — an outcome study. Br J Rheumatol 1993; 32:139–42.
  • Forseth KØ, Husby G, Gran JT, et al. Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Thematol 1999;26:2458–67.
  • Granges G, Zilko P, Littlejohn OG. Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 1994; 21:523–9.
  • Henriksson C. Longterm effects of fibromyalgia on everyday life. A study of 56 patients. Scand J Rheumatol 1994;23:36–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.